Skip to main content

Table 2 Comparison of adult participants with positive versus negative Trypanosoma cruzi serology according to sociodemographic and epidemiological variables

From: Community-based screening of Chagas disease among Latin American migrants in a non-endemic country: an observational study

 

T. cruzi positive

T. cruzi negative

P value

Demographic data

 Sex, male, n/N (%)

27/54 (50.0)

169/442 (38.2)

0.09

 Age (years), median (IQR)

44 (39–51)

41 (34–49)

0.038

 Time in Spain (years), median (IQR)

12.5 (11–15)

14 (11–16)

0.097

Education, n/N (%)

 Primary school

22/53 (41.5)

106/420 (25.2)

0.012

 Secondary school

26,753 (49.1)

239/420 (56.9)

0.28

 University studies

5/53 (9.4)

75/420 (17.9)

0.12

Country of birth, n/N (%)

 Bolivia

53/54 (98.1)

149/442 (37.7)

 < 0.001

 Ecuador

0/54 (0)

187/442 (42.2)

 < 0.001

 Colombia

0/54 (0)

65/442 (14.7)

0.003

 Argentina

1/54 (1.9)

12/442 (2.7)

0.70

 Brazil

0/54 (0)

7/442 (1.6)

0.32

 Paraguay

0/54 (0)

6 /442(1.4)

0.38

 Peru

0/54 (0)

4/442 (0.9)

0.99

 Venezuela

0/54 (0)

4/442 (0.9)

0.99

 Otherª

0/54 (0)

8 (1.6)

 

Epidemiological data, n/N (%)

 Living in rural area

16/20 (80.0)

135/181 (74.6)

0.32

 Triatomines seen at home

18/20 (90.0)

90/180 (50.0)

0.001

 Blood transfusion recipient

2/19 (10.5)

26/180 (14.4)

0.64

 Relatives with Chagas disease

9/21 (42.9)

29/182 (15.9)

0.003

 Having heard about Chagas disease

20/21 (95.2)

92/182 (50.5)

 < 0.001

 Positive Strongyloides stercoralis serology

14/54 (25.9)

46/442 (10.4)

0.001

 Previously underwent Chagas disease serology

18/53 (34.0)

40/476 (8.4)

 < 0.001

  1. IQR interquartile range
  2. ªOther countries: Nicaragua (n = 2), Uruguay (n = 2), Honduras (n = 2), Mexico (n = 2). In bold, statistically significant differences